Bcr-Abl(Bcr-Abl酪氨酸激酶)
Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).
Products for Bcr-Abl
- Cat.No. 产品名称 Information
-
GC14396
Ponatinib (AP24534)
普纳替尼; AP24534
An inhibitor of native and mutant Bcr-Abl -
GC15197
Saracatinib (AZD0530)
塞卡替尼; AZD0530
A dual inhibitor of c-Src and Abl -
GC11759
Imatinib Mesylate (STI571)
甲磺酸伊马替尼; STI571 Mesylate; CGP-57148B Mesylate
An inhibitor of c-Abl, Bcr-Abl, PDGFR, and c-Kit -
GC13343
Bosutinib (SKI-606)
伯舒替尼,SKI-606
An inhibitor of Src and Abl kinases -
GC14129
Nilotinib(AMN-107)
尼洛替尼; AMN107
Nilotinib(AMN-107)(尼洛替尼)是一种选择性口服酪氨酸激酶抑制剂,可抑制天然Bcr-Abl(WT p210)和突变型Bcr-Abl(E281K、E292K、F317L、M351T和F486S)的自磷酸化,IC50值分别为20、42、31、38、29和41nM。 -
GC13102
XL228
N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺,XL-228;XL 228
A tyrosine kinase inhibitor -
GC14237
Nilotinib monohydrochloride monohydrate
尼洛替尼盐酸盐一水合物; AMN107 monohydrochloride monohydrate
A Bcr-Abl inhibitor -
GC10914
AST 487
NVP-AST 487
A multi-kinase inhibitor -
GC14592
KW 2449
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
A multi-kinase inhibitor -
GC10638
AT9283
A broad spectrum kinase inhibitor
-
GC15568
Dasatinib (BMS-354825)
达沙替尼; BMS-354825
An inhibitor of Abl and Src